Skip to content
10-Q

Quarterly Report

Denali Therapeutics Inc. DNLI

0001714899-25-000170

← back to feed
Filed
Aug 11, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 5, 2025 146.21M sh
Shares Diluted Q2 2025 · Jun 30, 2025 171.45M sh
Shares Diluted Q2 2025 · Jun 30, 2025 171.34M sh
Shares Diluted Q2 2025 · Jun 30, 2024 168.83M sh
Shares Diluted Q2 2025 · Jun 30, 2024 159.12M sh
Capex Q2 2025 · Jun 30, 2025 $9.36M
Capex Q2 2025 · Jun 30, 2024 $6.94M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$206.77M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$204.84M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $141.21M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $174.96M
Stockholders Equity Q2 2025 · Jun 30, 2025 $1.03B
Stockholders Equity Q2 2025 · Mar 31, 2025 $1.12B
Stockholders Equity Q2 2025 · Dec 31, 2024 $1.23B
Stockholders Equity Q2 2025 · Jun 30, 2024 $1.39B
Stockholders Equity Q2 2025 · Mar 31, 2024 $1.46B
Stockholders Equity Q2 2025 · Dec 31, 2023 $1.03B
Current Liabilities Q2 2025 · Jun 30, 2025 $91.06M
Current Liabilities Q2 2025 · Dec 31, 2024 $102.21M
Total Liabilities Q2 2025 · Jun 30, 2025 $139.19M
Total Liabilities Q2 2025 · Dec 31, 2024 $144.5M
Current Assets Q2 2025 · Jun 30, 2025 $934.71M
Current Assets Q2 2025 · Dec 31, 2024 $864.44M
Total Assets Q2 2025 · Jun 30, 2025 $1.17B
Total Assets Q2 2025 · Dec 31, 2024 $1.37B
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.72
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.50
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.59
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.26
Eps Basic Q2 2025 · Jun 30, 2025 −$0.72
Eps Basic Q2 2025 · Jun 30, 2025 −$1.50
Eps Basic Q2 2025 · Jun 30, 2024 −$0.59
Eps Basic Q2 2025 · Jun 30, 2024 −$1.26
Sga Expense Q2 2025 · Jun 30, 2025 $32.27M
Sga Expense Q2 2025 · Jun 30, 2025 $61.62M
Sga Expense Q2 2025 · Jun 30, 2024 $25.19M
Sga Expense Q2 2025 · Jun 30, 2024 $50.43M
Rd Expense Q2 2025 · Jun 30, 2025 $102.7M
Rd Expense Q2 2025 · Jun 30, 2025 $218.92M
Rd Expense Q2 2025 · Jun 30, 2024 $91.4M
Rd Expense Q2 2025 · Jun 30, 2024 $198.42M
Net Income Q2 2025 · Jun 30, 2025 −$124.12M
Net Income Q2 2025 · Jun 30, 2025 −$257.09M
Net Income Q2 2025 · Jun 30, 2024 −$99.03M
Net Income Q2 2025 · Jun 30, 2024 −$200.83M
Operating Income Q2 2025 · Jun 30, 2025 −$134.96M
Operating Income Q2 2025 · Jun 30, 2025 −$280.54M
Operating Income Q2 2025 · Jun 30, 2024 −$116.59M
Operating Income Q2 2025 · Jun 30, 2024 −$234.31M